Amphetamine Elicits Opposing Actions on Readily Releasable and Reserve Pools for Dopamine

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Covey, Dan P ^a   Juliano, Steven A ^a   Garris, Paul A ^a  

^a ILLINOIS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; IN VIVO STUDY; NONHUMAN; POTENTIOMETRY; RAT; STIMULUS RESPONSE; UPREGULATION;

ACTION POTENTIALS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOPAMINERGIC NEURONS; ELECTRIC STIMULATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SECRETORY VESICLES; SYNAPTIC TRANSMISSION;

EID: 84877075943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060763     Document Type: Article

References (80)

1. Bales JW, Wagner AK, Kline AE, Dixon CE, (2009) Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev 33: 981-1003 S0149-7634(09)00045-1 [pii];10.1016/j.neubiorev.2009.03.011 [doi].
2. Howell LL, Kimmel HL, (2008) Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75: 196-217 S0006-2952(07)00538-2 [pii];10.1016/j.bcp.2007.08.003 [doi].
3. Carboni E, Imperato A, Perezzani L, Di Chiara G, (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-661.
4. Di Chiara G, Imperato A, (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85: 5274-5278.
5. Kuczenski R, Segal DS, Aizenstein ML, (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11: 2703-2712.
6. Kuczenski R, Melega WP, Cho AK, Segal DS, (1997) Extracellular dopamine and amphetamine after systemic amphetamine administration: comparison to the behavioral response. J Pharmacol Exp Ther 282: 591-596.
7. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR, (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47: 681-698 10.1146/annurev.pharmtox.47.120505.105140 [doi].
8. Sulzer D, (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69: 628-649.
9. Paladini CA, Fiorillo CD, Morikawa H, Williams JT, (2001) Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons. Nat Neurosci 4: 275-281.
10. Shi WX, Pun CL, Zhang XX, Jones MD, Bunney BS, (2000) Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J Neurosci 20: 3504-3511.
11. May LJ, Kuhr WG, Wightman RM, (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J Neurochem 51: 1060-1069.
12. Ramsson ES, Covey DP, Daberkow DP, Litherland MT, Juliano SA, et al. (2011) Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. J Neurochem 117: 937-948 10.1111/j.1471-4159.2011.07258.x [doi].
13. Daberkow DP, Brown HD, Bunner KD, Kraniotis SA, Doellman MA, et al. (2013) Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J Neurosci 33: 452-463 33/2/452 [pii];10.1523/JNEUROSCI.2136-12.2013 [doi].
14. Ramsson ES, Howard CD, Covey DP, Garris PA, (2011) High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. J Neurochem 119: 1162-1172 10.1111/j.1471-4159.2011.07407.x [doi].
15. Schultz W, (2007) Multiple dopamine functions at different time courses. Annu Rev Neurosci 30: 259-288 10.1146/annurev.neuro.28.061604.135722 [doi].
16. Rizzoli SO, Betz WJ, (2005) Synaptic vesicle pools. Nat Rev Neurosci 6: 57-69 nrn1583 [pii];10.1038/nrn1583 [doi].
17. Ewing AG, Bigelow JC, Wightman RM, (1983) Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 221: 169-171.
18. Michael AC, Ikeda M, Justice JB Jr, (1987) Dynamics of the recovery of releasable dopamine following electrical stimulation of the medial forebrain bundle. Neurosci Lett 76: 81-86.
19. Michael AC, Ikeda M, Justice JB Jr, (1987) Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation. Brain Res 421: 325-335.
20. Yavich L, MacDonald E, (2000) Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. Brain Res 870: 73-79.
21. Anderson BB, Chen G, Gutman DA, Ewing AG, (1998) Dopamine levels of two classes of vesicles are differentially depleted by amphetamine. Brain Res 788: 294-301.
22. Chen G, Ewing AG, (1995) Multiple classes of catecholamine vesicles observed during exocytosis from the Planorbis cell body. Brain Res 701: 167-174 0006-8993(95)00989-9 [pii].
23. Riddle EL, Hanson GR, Fleckenstein AE, (2007) Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. Eur J Pharmacol 571: 25-28 S0014-2999(07)00645-0 [pii];10.1016/j.ejphar.2007.05.044 [doi].
24. Dugast C, Suaud-Chagny MF, Gonon F, (1994) Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry. Neuroscience 62: 647-654.
25. Stamford JA, Kruk ZL, Millar J, (1986) Measurement of stimulated dopamine release in the rat by in vivo voltammetry: the influence of stimulus duration on drug responses. Neurosci Lett 69: 70-73 0304-3940(86)90416-7 [pii].
26. Robinson DL, Hermans A, Seipel AT, Wightman RM, (2008) Monitoring rapid chemical communication in the brain. Chem Rev 108: 2554-2584 10.1021/cr068081q [doi].
27. Cheer JF, Heien ML, Garris PA, Carelli RM, Wightman RM, (2005) Simultaneous dopamine and single-unit recordings reveal accumbens GABAergic responses: implications for intracranial self-stimulation. Proc Natl Acad Sci U S A 102: 19150-19155 0509607102 [pii];10.1073/pnas.0509607102 [doi].
28. Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, et al. (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25: 513-523.
29. Wu Q, Reith ME, Wightman RM, Kawagoe KT, Garris PA, (2001) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J Neurosci Methods 112: 119-133.
30. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. New York: Academic Press.
31. Wu Q, Reith ME, Kuhar MJ, Carroll FI, Garris PA, (2001) Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci 21: 6338-6347 21/16/6338 [pii].
32. Michael D, Travis ER, Wightman RM, (1998) Color images for fast-scan CV measurements in biological systems. Anal Chem 70: 586A-592A.
33. John CE, Jones SR, (2007) Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52: 1596-1605.
34. Keithley RB, Wightman RM, (2011) Assessing principal component regression prediction of neurochemicals detected with fast-scan cyclic voltammetry. ACS Chem Neurosci 2: 514-525 10.1021/cn200035u [doi].
35. Hermans A, Keithley RB, Kita JM, Sombers LA, Wightman RM, (2008) Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction. Anal Chem 80: 4040-4048 10.1021/ac800108j [doi].
36. Aragona BJ, Cleaveland NA, Stuber GD, Day JJ, Carelli RM, et al. (2008) Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci 28: 8821-8831 28/35/8821 [pii];10.1523/JNEUROSCI.2225-08.2008 [doi].
37. Wightman RM, Heien ML, Wassum KM, Sombers LA, Aragona BJ, et al. (2007) Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur J Neurosci 26: 2046-2054 EJN5772 [pii];10.1111/j.1460-9568.2007.05772.x [doi].
38. Koulchitsky S, De BB, Quertemont E, Charlier C, Seutin V, (2012) Differential effects of cocaine on dopamine neuron firing in awake and anesthetized rats. Neuropsychopharmacology 37: 1559-1571 npp2011339 [pii];10.1038/npp.2011.339 [doi].
39. Kuhr WG, Wightman RM, Rebec GV, (1987) Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle. Brain Res 418: 122-128 0006-8993(87)90968-1 [pii].
40. Montague PR, McClure SM, Baldwin PR, Phillips PE, Budygin EA, et al. (2004) Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci 24: 1754-1759 10.1523/JNEUROSCI.4279-03.2004 [doi];24/7/1754 [pii].
41. Venton BJ, Zhang H, Garris PA, Phillips PE, Sulzer D, et al. (2003) Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem 87: 1284-1295 2109 [pii].
42. Borland LM, Shi G, Yang H, Michael AC, (2005) Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat. J Neurosci Methods 146: 149-158 S0165-0270(05)00048-8 [pii];10.1016/j.jneumeth.2005.02.002 [doi].
43. Kelland MD, Chiodo LA, Freeman AS, (1990) Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Synapse 6: 207-209 10.1002/syn.890060213 [doi].
44. Owesson-White CA, Roitman MF, Sombers LA, Belle AM, Keithley RB, et al. (2012) Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J Neurochem 121: 252-262 10.1111/j.1471-4159.2012.07677.x [doi].
45. Oleson EB, Salek J, Bonin KD, Jones SR, Budygin EA, (2009) Real-time voltammetric detection of cocaine-induced dopamine changes in the striatum of freely moving mice. Neurosci Lett 467: 144-146.
46. Stuber GD, Roitman MF, Phillips PE, Carelli RM, Wightman RM, (2005) Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration. Neuropsychopharmacology 30: 853-863.
47. Kuhr WG, Ewing AG, Near JA, Wightman RM, (1985) Amphetamine attenuates the stimulated release of dopamine in vivo. J Pharmacol Exp Ther 232: 388-394.
48. Kuhr WG, Bigelow JC, Wightman RM, (1986) In vivo comparison of the regulation of releasable dopamine in the caudate nucleus and the nucleus accumbens of the rat brain. J Neurosci 6: 974-982.
49. Jones SR, Garris PA, Wightman RM, (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J Pharmacol Exp Ther 274: 396-403.
50. Scorza MC, Carrau C, Silveira R, Zapata-Torres G, Cassels BK, et al. (1997) Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships. Biochem Pharmacol 54: 1361-1369 S0006-2952(97)00405-X [pii].
51. Kuczenski R, (1975) Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase. Neuropharmacology 14: 1-10.
52. Ingram SL, Prasad BM, Amara SG, (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5: 971-978 10.1038/nn920 [doi];nn920 [pii].
53. Mundorf ML, Hochstetler SE, Wightman RM, (1999) Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J Neurochem 73: 2397-2405.
54. Fleckenstein AE, Volz TJ, Hanson GR, (2009) Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology 56 Suppl 1: 133-138 S0028-3908(08)00273-6 [pii];10.1016/j.neuropharm.2008.07.002 [doi].
55. Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, et al. (2007) Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J Pharmacol Exp Ther 323: 738-745 jpet.107.126888 [pii];10.1124/jpet.107.126888 [doi].
56. Bowyer JF, Masserano JM, Weiner N, (1987) Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes. J Pharmacol Exp Ther 240: 177-186.
57. Floor E, Meng L, (1996) Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci Lett 215: 53-56 S0304-3940(96)12963-3 [pii].
58. Jones SR, Gainetdinov RR, Wightman RM, Caron MG, (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18: 1979-1986.
59. Mosharov EV, Gong LW, Khanna B, Sulzer D, Lindau M, (2003) Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells. J Neurosci 23: 5835-5845 23/13/5835 [pii].
60. Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA, (2003) Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J Neurochem 85: 898-910 1732 [pii].
61. Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D, (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 21: 5916-5924.
62. Cass WA, Gerhardt GA, Mayfield RD, Curella P, Zahniser NR, (1992) Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J Neurochem 59: 259-266.
63. Marshall JF, O'Dell SJ, Navarrete R, Rosenstein AJ, (1990) Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuroscience 37: 11-21 0306-4522(90)90187-9 [pii].
64. Lew R, Patel A, Vaughan RA, Wilson A, Kuhar MJ, (1992) Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens. Brain Res 584: 266-271 0006-8993(92)90905-O [pii].
65. Avelar AJ, Juliano SA, Garris PA, (2013) Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms. J Neurochem in press.
66. Hondebrink L, Meulenbelt J, Timmerman JG, van den Berg M, Westerink RH, (2009) Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure. J Neurochem 111: 624-633 JNC6357 [pii];10.1111/j.1471-4159.2009.06357.x [doi].
67. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, et al. (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71: 1289-1297.
68. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, et al. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15: 4102-4108.
69. Kile BM, Guillot TS, Venton BJ, Wetsel WC, Augustine GJ, et al. (2010) Synapsins differentially control dopamine and serotonin release. J Neurosci 30: 9762-9770 30/29/9762 [pii];10.1523/JNEUROSCI.2071-09.2010 [doi].
70. Lee TH, Balu R, Davidson C, Ellinwood EH, (2001) Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. Synapse 41: 301-310 10.1002/syn.1087 [pii];10.1002/syn.1087 [doi].
71. Venton BJ, Seipel AT, Phillips PE, Wetsel WC, Gitler D, et al. (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26: 3206-3209.
72. Benwell ME, Balfour DJ, Lucchi HM, (1993) Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology (Berl) 112: 467-474.
73. Nomikos GG, Damsma G, Wenkstern D, Fibiger HC, (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6: 106-112 10.1002/syn.890060113 [doi].
74. Westerink BH, Tuntler J, Damsma G, Rollema H, de Vries JB, (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn Schmiedebergs Arch Pharmacol 336: 502-507.
75. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, et al. (2007) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27: 791-795 27/4/791 [pii];10.1523/JNEUROSCI.4152-06.2007 [doi].
76. Robinson DL, Howard EC, McConnell S, Gonzales RA, Wightman RM, (2009) Disparity between tonic and phasic ethanol-induced dopamine increases in the nucleus accumbens of rats. Alcohol Clin Exp Res 33: 1187-1196 ACER942 [pii];10.1111/j.1530-0277.2009.00942.x [doi].
77. Hyman SE, Malenka RC, Nestler EJ, (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598 10.1146/annurev.neuro.29.051605.113009 [doi].
78. Wiecki TV, Frank MJ, (2010) Neurocomputational models of motor and cognitive deficits in Parkinson's disease. Prog Brain Res 183: 275-297 S0079-6123(10)83014-6 [pii];10.1016/S0079-6123(10)83014-6 [doi].
79. Everitt BJ, Robbins TW, (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489 nn1579 [pii];10.1038/nn1579 [doi].
80. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, (2011) Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A 108: 15037-15042 1010654108 [pii];10.1073/pnas.1010654108 [doi].